Search Results - "TOKUNAGA, Eriko"

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer by Modi, Shanu, Saura, Cristina, Yamashita, Toshinari, Park, Yeon Hee, Kim, Sung-Bae, Tamura, Kenji, Andre, Fabrice, Iwata, Hiroji, Ito, Yoshinori, Tsurutani, Junji, Sohn, Joohyuk, Denduluri, Neelima, Perrin, Christophe, Aogi, Kenjiro, Tokunaga, Eriko, Im, Seock-Ah, Lee, Keun Seok, Hurvitz, Sara A, Cortes, Javier, Lee, Caleb, Chen, Shuquan, Zhang, Lin, Shahidi, Javad, Yver, Antoine, Krop, Ian

“…In this single-group, phase 2 study, the use of trastuzumab deruxtecan resulted in a response in 60% of women with HER2-positive advanced breast cancer who had…”
Get full text

DNA replication stress and cancer chemotherapy by Kitao, Hiroyuki, Iimori, Makoto, Kataoka, Yuki, Wakasa, Takeshi, Tokunaga, Eriko, Saeki, Hiroshi, Oki, Eiji, Maehara, Yoshihiko

“…DNA replication is one of the fundamental biological processes in which dysregulation can cause genome instability. This instability is one of the hallmarks of…”
Get full text

Topochemical synthesis and catalysis of metal nanoparticles exposed on crystalline cellulose nanofibers by Koga, Hirotaka, Tokunaga, Eriko, Hidaka, Mami, Umemura, Yuuka, Saito, Tsuguyuki, Isogai, Akira, Kitaoka, Takuya

“…Topochemical synthesis of gold nanoparticles (AuNPs) was achieved on crystalline cellulose single nanofibers (CSNFs), which were tailored from native…”
Get more information

Thermoelectric properties of sorted semiconducting single-walled carbon nanotube sheets by Huang, Wenxin, Tokunaga, Eriko, Nakashima, Yuki, Fujigaya, Tsuyohiko

“…Single-walled carbon nanotubes (SWNTs), especially their semiconducting type, are promising thermoelectric (TE) materials due to their high Seebeck…”
Get full text

Developing a questionnaire on the quality of working life for female medical and healthcare professionals by TAKETOMI, Kikuko, ITO, Yoichi M., TOKUNAGA, Eriko, HIRANO, Yuko O., FUJINO, Yuriko, CHISHAKI, Akiko

“…This study aimed to develop a questionnaire on the quality of working life among female medical and healthcare professionals and examine its validity and…”
Get full text

Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer by Iwase, Madoka, Ando, Masashi, Aogi, Kenjiro, Aruga, Tomoyuki, Inoue, Kenichiro, Shimomura, Akihiko, Tokunaga, Eriko, Masuda, Norikazu, Yamauchi, Hideko, Yamashita, Toshinari, Iwata, Hiroji

“…Purpose Addition of carboplatin (CBDCA) to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) has improved pathological complete response…”
Get full text

Deregulation of the Akt pathway in human cancer by Tokunaga, Eriko, Oki, Eiji, Egashira, Akinori, Sadanaga, Noriaki, Morita, Masaru, Kakeji, Yoshihiro, Maehara, Yoshihiko

“…Akt (protein kinase B) is a serine/threonine kinase which is a central regulator of widely divergent cellular processes including proliferation,…”
Get more information

Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry by Kataoka, Akemi, Iwamoto, Takayuki, Tokunaga, Eriko, Tomotaki, Ai, Kumamaru, Hiraku, Miyata, Hiroaki, Niikura, Naoki, Kawai, Masaaki, Anan, Keisei, Hayashi, Naoki, Masuda, Shinobu, Tsugawa, Koichiro, Aogi, Kenjiro, Ishida, Takanori, Masuoka, Hideji, Iijima, Kotaro, Kinoshita, Takayuki, Nakamura, Seigo, Tokuda, Yutaka

“…Purpose The aim of this study was to investigate whether young age at onset of breast cancer is an independent prognostic factor in patients from the Japanese…”
Get full text

Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study by Tanaka, Kiyo, Masuda, Norikazu, Hayashi, Naoki, Sagara, Yasuaki, Hara, Fumikata, Kadoya, Takayuki, Matsui, Akira, Miyazaki, Chieko, Shien, Tadahiko, Tokunaga, Eriko, Hayashi, Takako, Niikura, Naoki, Maeda, Shigeto, Komoike, Yoshihumi, Bando, Hiroko, Kanbayashi, Chizuko, Iwata, Hiroji

“…Background We conducted a prospective study with the intention to omit surgery for patients with ductal carcinoma in situ (DCIS) of the breast. We aimed to…”
Get full text

Molecular mechanisms regulating the hormone sensitivity of breast cancer by Tokunaga, Eriko, Hisamatsu, Yuichi, Tanaka, Kimihiro, Yamashita, Nami, Saeki, Hiroshi, Oki, Eiji, Kitao, Hiroyuki, Maehara, Yoshihiko

“…Breast cancer is a heterogeneous disease. Approximately 70% of breast cancers are estrogen receptor (ER) positive. Endocrine therapy has dramatically improved…”
Get full text

Bilateral breast metastases from anaplastic lymphoma kinase-positive lung cancer in a male: a case report by Koh, Sumire, Koi, Yumiko, Tajiri, Wakako, Kawasaki, Junji, Akiyoshi, Sayuri, Nakamura, Yoshiaki, Koga, Chinami, Okamoto, Tatsuro, Taguchi, Kenichi, Tokunaga, Eriko

“…Distant metastases from lung cancer are commonly found in the brain, bone, and liver. Metastases to the breast from non-mammary malignancies are extremely…”
Get full text

Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan by Miyashita, Mika, Ohno, Shinji, Kataoka, Akemi, Tokunaga, Eriko, Masuda, Norikazu, Shien, Tadahiko, Kawabata, Kimiko, Takahashi, Miyako

“…BACKGROUND:Young breast cancer survivors have specific needs related to age. Clarifying the relationships between unmet information needs and quality of life…”
Get full text

Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer by Takahashi, Masato, Tokunaga, Eriko, Mori, Joji, Tanizawa, Yoshinori, van der Walt, Jan-Stefan, Kawaguchi, Tsutomu, Goetz, Matthew P., Toi, Masakazu

“…Background This was a Japanese subpopulation analysis of MONARCH 3, a randomized, double-blind, placebo-controlled phase 3 study of abemaciclib plus…”
Get full text

Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy by Tokunaga, Eriko, Masuda, Takanobu, Ijichi, Hideki, Tajiri, Wakako, Koga, Chinami, Koi, Yumiko, Nakamura, Yoshiaki, Ohno, Shinji, Taguchi, Kenichi, Okamoto, Masahiro

“…Background Several studies have recently reported that the relationships between serum vitamin D and the prognosis or the pathological response to neoadjuvant…”
Get full text

A dramatic response to an immune checkpoint inhibitor plus chemotherapy in a patient with metastatic metaplastic carcinoma of the breast: A case report by Koi, Yumiko, Tajiri, Wakako, Kawasaki, Junji, Akiyoshi, Sayuri, Ijichi, Hideki, Nakamura, Yoshiaki, Koga, Chinami, Koga, Yutaka, Taguchi, Kenichi, Tokunaga, Eriko

“…We present a unique case of metastatic metaplastic breast carcinoma responding dramatically to immunochemotherapy. A 46‐year‐old Japanese woman with primary…”
Get full text

Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women by Tokunaga, Eriko, Yamashita, Nami, Tanaka, Kimihiro, Inoue, Yuka, Akiyoshi, Sayuri, Saeki, Hiroshi, Oki, Eiji, Kitao, Hiroyuki, Maehara, Yoshihiko

“…Recent studies have identified the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3B (APOBEC3B) as a source of mutations in various…”
Get full text

Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial by Iwata, Hiroji, Nakamura, Rikiya, Masuda, Norikazu, Yamashita, Toshinari, Yamamoto, Yutaka, Kobayashi, Kokoro, Tsurutani, Junji, Iwasa, Tsutomu, Yonemori, Kan, Tamura, Kenji, Aruga, Tomoyuki, Tokunaga, Eriko, Kaneko, Koji, Lee, Min-Jung, Yuno, Akira, Kawabata, Azusa, Seike, Toshihiro, Kaneda, Ayumi, Nishimura, Yozo, Trepel, Jane B, Saji, Shigehira

“…We aimed to confirm the efficacy and safety of the oral histone deacetylase inhibitor entinostat in Japanese patients with hormone receptor-positive…”
Get full text

A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17) by Fukada, Ippei, Ito, Yoshinori, Kondo, Naoto, Ohtani, Shoichiro, Hattori, Masaya, Tokunaga, Eriko, Matsunami, Nobuki, Mashino, Kohjiro, Kosaka, Taijiro, Tanabe, Masahiko, Yotsumoto, Daisuke, Yamanouchi, Kosho, Sawaki, Masataka, Kashiwaba, Masahiro, Kawabata, Hidetaka, Kuroi, Katsumasa, Morita, Satoshi, Ohno, Shinji, Toi, Masakazu, Masuda, Norikazu

“…Purpose The sequence of taxanes (T) followed by anthracyclines (A) as neoadjuvant chemotherapy has been the standard of care for almost 20 years for locally…”
Get full text

Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2−, node-positive, high-risk early breast cancer by Paluch-Shimon, Shani, Neven, Patrick, Huober, Jens, Cicin, Irfan, Goetz, Matthew P., Shimizu, Chikako, Huang, Chiun-Sheng, Lueck, Hans Joachim, Beith, Jane, Tokunaga, Eriko, Contreras, Jessica Reyes, de Sant’Ana, Rosane Oliveira, Wei, Ran, Shahir, Ashwin, Nabinger, Sarah C., Forrester, Tammy, Johnston, Stephen R. D., Harbeck, Nadia

“…Background: Abemaciclib is the first and only cyclin-dependent kinases 4 and 6 inhibitor approved for adjuvant treatment of hormone receptor-positive (HR+),…”
Get full text

A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy by Ohsumi, Shozo, Nishimura, Reiki, Masuda, Norikazu, Akashi-Tanaka, Sadako, Suemasu, Kimito, Yamauchi, Hideko, Tokunaga, Eriko, Ikeda, Tadashi, Nishi, Tsunehiro, Hayashi, Hiroto, Iino, Yuichi, Takatsuka, Yuichi, Ohashi, Yasuo, Inaji, Hideo

“…Background Breast-conserving surgery with radiotherapy is one of standard treatments for early breast cancer. However, it is regarded as an option to treat…”
Get full text